Share on StockTwits
 

Medidata Solutions (NASDAQ:MDSO) posted its quarterly earnings results on Thursday. The company reported $0.23 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.17 by $0.06, Analyst Ratings Network reports. The company had revenue of $74.60 million for the quarter, compared to the consensus estimate of $73.97 million.

Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Medidata Solutions from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, January 8th. They now have a $62.40 price target on the stock. On a related note, analysts at B. Riley raised their price target on shares of Medidata Solutions to $160.00 in a research note to investors on Tuesday, November 26th. They now have a “neutral” rating on the stock. Finally, analysts at Deutsche Bank initiated coverage on shares of Medidata Solutions in a research note to investors on Wednesday, November 20th. They set a “buy” rating and a $133.00 price target on the stock. They noted that the move was a valuation call. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Medidata Solutions currently has an average rating of “Buy” and a consensus price target of $108.55.

Medidata Solutions (NASDAQ:MDSO) opened at 58.06 on Thursday. Medidata Solutions has a 1-year low of $23.56 and a 1-year high of $66.01. The stock has a 50-day moving average of $60.68 and a 200-day moving average of $52.71. The company has a market cap of $2.992 billion and a P/E ratio of 133.67.

Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.